Skip to main content
. 2019 Sep-Oct;23(5):575–579. doi: 10.4103/ijem.IJEM_271_19

Table 2.

Clinical profile of patients with 5α-reductase type-2 deficiency

Age at presentation Consanguity Clinical phenotype HCG stimultated T/DHT ratio
2 months Yes Penoscrotal hypospadias 31.9
1 month Yes Micropenis; Penoscrotal hypospadias 21.2
Birth Yes Bifid scrotum; Perineal hypospadias 36.8
3 months Yes Bifid scrotum; Penoscrotal hypospadias 30.2
4 years No Bifid scrotum; Penoscrotal hypospadias 26.0
2 day No Bifid scrotum; Perineal hypospadias 42.0
Birth No Penoscrotal hypospadias 52.8
1 month Yes Micropenis; Bifid scrotum 71.0
13 years Yes Penoscrotal hypospadias 65.2
3 months Yes Micropenis; Penoscrotal hypospadias 75.4
Birth No Penoscrotal hypospadias 47.4
Birth No Micropenis; Penoscrotal hypospadias 54.0
13 years No Bifid scrotum; Perineal hypospadias 25.0
1 year and 6 months Yes Micropenis; Penoscrotal hypospadias 33.6
3 months No Micropenis; Perineal hypospadias; Bifid scrotum 55.5
2 years No Micropenis; Penoscrotal hypospadias 27.3
Birth Yes Micropenis; Bifid scrotum 29.8

HCG: Human chorionic gonadotropin; T: Testosterone; DHT: Dihydrotestosterone